IFF icon

International Flavors & Fragrances

72.50 USD
+1.44
2.03%
At close Apr 17, 4:00 PM EDT
After hours
74.00
+1.50
2.07%
1 day
2.03%
5 days
2.20%
1 month
-11.63%
3 months
-14.60%
6 months
-30.55%
Year to date
-12.75%
1 year
-12.49%
5 years
-42.06%
10 years
-37.65%
 

About: International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.

Employees: 22,400

0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

211% more call options, than puts

Call options by funds: $212M | Put options by funds: $68.3M

4.27% more ownership

Funds ownership: 88.68% [Q3] → 92.95% (+4.27%) [Q4]

3% less funds holding

Funds holding: 775 [Q3] → 749 (-26) [Q4]

13% less first-time investments, than exits

New positions opened: 95 | Existing positions closed: 109

16% less capital invested

Capital invested by funds: $23.8B [Q3] → $20.1B (-$3.69B) [Q4]

28% less repeat investments, than reductions

Existing positions increased: 226 | Existing positions reduced: 314

38% less funds holding in top 10

Funds holding in top 10: 16 [Q3] → 10 (-6) [Q4]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$76
5%
upside
Avg. target
$93
28%
upside
High target
$104
43%
upside

9 analyst ratings

positive
89%
neutral
11%
negative
0%
Mizuho
John Roberts
8% 1-year accuracy
3 / 39 met price target
20%upside
$87
Outperform
Maintained
15 Apr 2025
Barclays
Lauren Lieberman
52% 1-year accuracy
48 / 92 met price target
5%upside
$76
Equal-Weight
Maintained
14 Apr 2025
Morgan Stanley
Lisa De Neve
50% 1-year accuracy
1 / 2 met price target
38%upside
$100
Overweight
Maintained
10 Apr 2025
Stifel
Mark Astrachan
50% 1-year accuracy
15 / 30 met price target
26%upside
$91
Buy
Maintained
10 Apr 2025
Wells Fargo
Michael Sison
25% 1-year accuracy
13 / 53 met price target
24%upside
$90
Overweight
Maintained
9 Apr 2025

Financial journalist opinion

Based on 12 articles about IFF published over the past 30 days

Neutral
Business Wire
2 days ago
IFF Opens Dubai Creative Center With Perfumery Art Studio
DUBAI, United Arab Emirates--(BUSINESS WIRE)--IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company's facility in the Dubai Science Park Laboratory Complex. The added facility strengthens IFF's capabilities to serve customers with leading fragrance innovations in one of the fastest-growing regions in the global scent industry. "The Middle East is a key market for IFF's global growth,” said Erik Fyrwald, IFF CEO. “It's expecte.
IFF Opens Dubai Creative Center With Perfumery Art Studio
Neutral
Business Wire
3 days ago
IFF to Release First Quarter 2025 Results on May 6, 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version.
IFF to Release First Quarter 2025 Results on May 6, 2025
Positive
Zacks Investment Research
3 days ago
International Flavors to Boost Presence in Mexico With New Facility
IFF plans to consolidate the majority of its business operations in Mexico at a new site within the Tecnoparque business complex to meet customer demand in the region.
International Flavors to Boost Presence in Mexico With New Facility
Positive
Zacks Investment Research
1 week ago
Strength Seen in International Flavors (IFF): Can Its 9.2% Jump Turn into More Strength?
International Flavors (IFF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Strength Seen in International Flavors (IFF): Can Its 9.2% Jump Turn into More Strength?
Neutral
Business Wire
1 week ago
IFF Opens Mexico Business Hub at Tecnoparque
NEW YORK--(BUSINESS WIRE)--To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at a new site in Mexico City within the Tecnoparque business complex. The move will begin immediately with its Global Business Services Center—which supports the company's full business capabilities serving Mexican and Latin American markets—and is expected to finalize by 2026. IFF's new facilities w.
IFF Opens Mexico Business Hub at Tecnoparque
Neutral
Business Wire
1 week ago
IFF Unveils Cutting-Edge Citrus Innovation Center in Florida
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot facility encompasses state-of-the-art capabilities in botanical research leveraging its LMR by IFF natural ingredients expertise, processing, analytics, product creation for scent and taste, and includes a 360-degree digital immersion room. Designed with sustainability in mind, the center offers j.
IFF Unveils Cutting-Edge Citrus Innovation Center in Florida
Neutral
Business Wire
1 week ago
IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages. This innovative product line addresses the industry's concern with nitrosamine risk and mitigation strategies for their formation. Through enhanced process controls and industry-.
IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation
Neutral
Business Wire
2 weeks ago
IFF Introduces Science of Performance: A New Approach to Elevating Scent Design
PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to manage scent intensity and control malodors. The program combines decades of measured data enhanced by proprietary AI capabilities, along with advanced sensory, technical, consumer and market expertise in various end-user applications. "Science of Performance is a unique approach to scent performance.
IFF Introduces Science of Performance: A New Approach to Elevating Scent Design
Neutral
Business Wire
3 weeks ago
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production wi.
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
Neutral
Business Wire
3 weeks ago
IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025
TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral disintegrating tablets (ODTs), controlled-release formulations, and novel complex formulations at booth 5K-21, Tokyo Big Sight East Halls 4-6, April 9-11. “IFF Pharma Solutions is committed to redefining drug delivery through material science innovation,” said Frank Zhao, commercial leader, IFF Phar.
IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025
Charts implemented using Lightweight Charts™